Suppr超能文献

[阿托品和胃复安对健康受试者柳氮磺胺吡啶口腔至盲肠转运时间的影响]

[Modification of orocecal transit time of salazosulfapyridine by atropine and metoclopramide in healthy probands].

作者信息

Terhaag B, Neugebauer A

出版信息

Dtsch Z Verdau Stoffwechselkr. 1986;46(6):327-32.

PMID:2881772
Abstract

The first appearance of sulpharyridine in plasma was investigated in nine healthy informed male volunteers. In a three way crossover design 6 g salazopyrin alone, together with metoclopramide (0.3 mg/kg i.m.) or atropine (0.01 mg/kg i.m.) were given. Sulphapyridine appears in the blood at the (means +/- S means) 6.2 h +/- 0.8 h (range: 3-11 h) in controls. Together with metoclopramide the first appearance is 3.6 h +/- 0.7 h (range: 2-8 h) and together with atropine these values are 8.1 +/- 0.8 h (range: 6-12 h). The differences are significant with p less than 0.05. The results show the pharmacological modification of motility in the gastrointestinal tract and in consequence the usefulness of salazopyridine to determine the transit time.

摘要

在9名健康且知情的男性志愿者中研究了柳氮磺胺吡啶在血浆中的首次出现情况。采用三交叉设计,分别给予6克单独的柳氮磺胺吡啶、柳氮磺胺吡啶与甲氧氯普胺(0.3毫克/千克,肌肉注射)或阿托品(0.01毫克/千克,肌肉注射)。在对照组中,磺胺吡啶在血液中首次出现的时间为(均值±标准误)6.2小时±0.8小时(范围:3 - 11小时)。与甲氧氯普胺一起时,首次出现时间为3.6小时±0.7小时(范围:2 - 8小时),与阿托品一起时,这些值为8.1±0.8小时(范围:6 - 12小时)。差异具有显著性,p值小于0.05。结果显示了胃肠道动力的药理学改变,因此柳氮磺胺吡啶在确定转运时间方面是有用的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验